Posted in

[Technology Collaboration] Syneron Bio and AstraZeneca enters a 3.5 billion USD Collaboration on oral macrocyclic peptide drug research

Announced Date: 2025-03-21 (March 21, 2025) Licensor: Syneron Bio (China) Licensee: AstraZeneca(UK) Collaboration Object: Co-develop potential … [Technology Collaboration] Syneron Bio and AstraZeneca enters a 3.5 billion USD Collaboration on oral macrocyclic peptide drug researchRead more